PDCD1 and cancer: Besides, the immune checkpoint blockade targeting PD-1 inhibitory pathways has been a successful treatment in several cancers; the blocking of these inhibitory immune checkpoint receptors is also associated with further irAEs that can resemble lupus-like autoimmune diseases (112, 113).